Refresher Course: Abdominal and Gastrointestinal

RC 201 - Preneoplastic lesions in hepato-pancreato-biliary (HPB) system: see and wait?

Lectures

1
Chairperson's introduction

Chairperson's introduction

03:00Charikleia Triantopoulou, Athens / GR

2
Preneoplastic liver lesions: distinguishing the harmless from the dangerous

Preneoplastic liver lesions: distinguishing the harmless from the dangerous

15:00Roberto Cannella, Palermo / IT

3
Biliary and gallbladder preneoplastic conditions: ignore, monitor, or operate?

Biliary and gallbladder preneoplastic conditions: ignore, monitor, or operate?

15:00Martina Pezzullo, Brussels / BE

4
Pancreatic cystic lesions: how not to overcall or overlook

Pancreatic cystic lesions: how not to overcall or overlook

15:00Nikolaos Kartalis, Stockholm / SE

5
Panel discussion: How to share knowledge and responsibility in multidisciplinary teams

Panel discussion: How to share knowledge and responsibility in multidisciplinary teams

12:00Panel discussion: How to share knowledge and responsibility in multidisciplinary teams

3 min
Chairperson's introduction
Charikleia Triantopoulou, Athens / Greece
15 min
Preneoplastic liver lesions: distinguishing the harmless from the dangerous
Roberto Cannella, Palermo / Italy
  1. To review the imaging features of regenerative and dysplastic nodules in cirrhosis.
  2. To identify risk factors and imaging signs of progression to hepatocellular carcinoma.
  3. To propose imaging follow-up strategies and thresholds for intervention.
15 min
Biliary and gallbladder preneoplastic conditions: ignore, monitor, or operate?
Martina Pezzullo, Brussels / Belgium
  1. To understand the imaging spectrum of biliary intraepithelial neoplasia (BilIN), intraductal papillary neoplasm of the bile duct (IPNB), and gallbladder polyps.
  2. To learn size, morphology, and enhancement features that raise concern.
  3. To align radiological findings with surgical and oncologic decision-making.
15 min
Pancreatic cystic lesions: how not to overcall or overlook
Nikolaos Kartalis, Stockholm / Sweden
  1. To differentiate between intraductal papillary mucinous neoplasm (IPMN), mucinous cystic neoplasm (MCN), and other cystic lesions based on imaging criteria.
  2. To apply risk stratification systems and guidelines.
  3. To outline practical surveillance intervals and indications for resection.
12 min
Panel discussion: How to share knowledge and responsibility in multidisciplinary teams

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.